Dimercaprol bulk supplier for pharma manufacturers

Dimercaprol 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg/mL

Reference Brands: B.A.L (USA)

Dimercaprol is a Critical Care product available as Injection in strengths 100 mg/mL. It corresponds to the reference brand B.A.L (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Dimercaprol, also known as British Anti-Lewisite (BAL), is a chelating agent widely used in the treatment of acute heavy metal poisoning. It is primarily indicated for poisoning caused by arsenic, mercury, gold, and severe lead exposure, and has also been used in cases involving antimony, thallium, and bismuth, although evidence for these uses is more limited. Dimercaprol is administered by deep intramuscular injection and is typically reserved for emergency and critical care situations due to its potent action and potential adverse effects.

For many years, dimercaprol has been a cornerstone of chelation therapy, particularly in cases of arsenic and lead poisoning, and it is recognized as an essential medicine. It is also an established antidote to the organometallic chemical warfare agent Lewisite. Because of its toxicity profile, safer oral chelating agents such as succimer have been developed; however, dimercaprol remains important in severe or life-threatening poisonings. Additionally, dimercaprol is approved for the treatment of Wilson’s disease, a genetic disorder characterized by excessive copper accumulation in the body, due to its ability to chelate copper. Experimental studies have also shown its potential to neutralize snake venom activity by binding zinc ions required for venom metalloproteinases.

Dimercaprol — third party manufacturing & bulk supply

Dimercaprol 100 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Dimercaprol is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Dimercaprol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Dimercaprol →

Back to Listing

Frequently Asked Questions

Dimercaprol is used as an antidote for the treatment of acute heavy metal poisoning. It is effective in cases of arsenic, mercury, gold, and severe lead poisoning, often used in emergency and critical care settings to reduce toxic effects.

Dimercaprol is a synthetic chelating agent containing sulfhydryl groups that bind to heavy metals. These complexes are then excreted from the body, helping to eliminate toxic metals from tissues.

The trade name of dimercaprol is BAL in Oil, also known as British Anti-Lewisite.

Dimercaprol is manufactured by various pharmaceutical companies globally, primarily for hospital and emergency use. The original product BAL was developed for military and toxicology applications.

The generic name of the product is dimercaprol.

The brand name of dimercaprol is BAL

Dimercaprol is manufactured in different countries depending on the supplier, including the USA, EU member states, and India, in compliance with international pharmaceutical quality standards.